The Head of HALMED held a lecture on the Lareb conference on reporting suspected adverse reactions from patients
30.04.2015
The Head of the Agency for Medicinal Products and Medical Devices (HALMED), Viola Macolić Šarinić, MD, PhD, held a lecture on the conference "Current perspectives and future possibilities”, dedicated to reporting suspected adverse reactions from patients, organised by Lareb in Leiden in the Netherlands from 23 to 24 April 2015.
In her lecture, the Head of HALMED presented the media tools for raising awareness on the importance of spontaneous adverse reactions reporting among patients and transmitted HALMED’s previous experience and pharmacovigilance successes in the field.
The Head presented positive results, achieved by HALMED in the field of reporting adverse reactions, when it was first in the world to use the UMC’s on-line application for patient reporting. She also presented the exceptionally successful HALMED’s public educational campaign for promoting the importance of package leaflet reading and reporting adverse reactions and emphasised that this campaign had resulted in a three-fold increase in number of received reports from patients. The innovative co-operation started by HALMED with the theatre "Small Scene” with the aim to promote the importance of rational use of medicines and reporting of suspected adverse reactions among children, adolescents and adults was specially highlighted.
The Head of HALMED emphasised that the HALMED’s pharmacovigilance activities continuously lead to an increase of suspected adverse reaction reports from patients, which is an exceptional success, confirming that patients have recognised their role and importance in monitoring the safety of medicines.
